Meteorin Is a Novel Therapeutic Target for Wet Age-Related Macular Degeneration.

MLA

Delaunay, Kimberley, et al. “Meteorin Is a Novel Therapeutic Target for Wet Age-Related Macular Degeneration.” Journal of Clinical Medicine, vol. 10, no. 13, July 2021. EBSCOhost, https://doi.org/10.3390/jcm10132973.

APA

Delaunay, K., Sellam, A., Dinet, V., Moulin, A., Zhao, M., Gelizé, E., Canonica, J., Naud, M.-C., Crisanti-Lassiaz, P., & Behar-Cohen, F. (2021). Meteorin Is a Novel Therapeutic Target for Wet Age-Related Macular Degeneration. Journal of Clinical Medicine, 10(13). https://doi.org/10.3390/jcm10132973

Chicago

Delaunay, Kimberley, Alexandre Sellam, Virginie Dinet, Alexandre Moulin, Min Zhao, Emmanuelle Gelizé, Jérémie Canonica, Marie-Christine Naud, Patricia Crisanti-Lassiaz, and Francine Behar-Cohen. 2021. “Meteorin Is a Novel Therapeutic Target for Wet Age-Related Macular Degeneration.” Journal of Clinical Medicine 10 (13). doi:10.3390/jcm10132973.